Concepedia

Leilai Xu

LX

3

Publications

123

Citations

3

H-Index

2015

Active since

Affiliations

Zhejiang Chinese Medical University(Current)

Leilai Xu is an author at Zhejiang Chinese Medical University specializing in tumor biology, medicine, and breast cancer.

ORCID

Top concepts

Publications per year

2015–2022

3

Publications

3

The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer

Xiaohong Xie, Yuanyuan Hu, Leilai Xu et al. · Tumor Biology · 2015 · 60 citations

Cantharidin suppressed breast cancer MDA-MB-231 cell growth and migration by inhibiting MAPK signaling pathway

Xidong Gu, Leilai Xu, Hong Zhao et al. · Brazilian Journal of Medical and Biological Research · 2017 · 43 citations · Full text

, , +14

β-elemene induced apoptosis and senescence of triple-negative breast cancer cells through IGF1/IGF1R pathway

Lufan Xie, Jianfeng Zhang, Haibin Yan et al. · Tissue and Cell · 2022 · 20 citations

, , +11

Rows per page

1–3 of 3